Author(s):
Ranjit Ambad, Roshan Kumar Jha, Dhruba Hari Chandi, Saurabh Hadke
Email(s):
ambad.sawan@gmail.com
DOI:
10.5958/0974-360X.2020.01095.1 
Address:
Dr. Ranjit Ambad1*, Mr. Roshan Kumar Jha2, Dhruba Hari Chandi3, Dr. Saurabh Hadke4
1Associate Professor Dept. of Biochemistry Datta Meghe Medical College, Shalinitai Meghe Hospital and Research Centre, Nagpur.
2Tutor, Dept. of Biochemistry Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha.
3Assistant Professor Dept. of Microbiology Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha.
4Assistant Professor Dept. of Medicine Datta Meghe Medical College, Shalinitai Meghe Hospital and Research Centre, Nagpur.
*Corresponding Author
Published In:
Volume - 13,
Issue - 12,
Year - 2020
ABSTRACT:
INTRODUCTION: Diabetes mellitus is collectively a metabolic disorder and is characterised by long term hyperglycemia due to defect in insulin secretion, insulin action or by both of them. Type 2diabetes accounts approximately 90% of cases, it develops micro vascular and macro vascular complications which causes psychological and physical distress and puts a huge burden on the health care system and providers. Obese subjects generally persists high level of leptin which correlate with BMI and body fat percentage. Although correlation between BMI and leptin exists. In men, BMI was the variable which was most strongly correlated with leptin. AIM: This study was aimed to analyse in depth the latent role of leptin in a mechanism underlying obesity and type 2 diabetes mellitus. To this end, suggestive markers of type 2 diabetes mellitus and obesity were estimated in blood samples and its association with leptin was observed MATERIAL AND METHODS: The study was designed to be cross sectional observational study for the period of one year in tertiary care hospital in India. The study consisted of face to face questionnaire interviews, physical examinations, and laboratory analysis.200 Subjects were enrolled in present studies among them 50 of them were males and rest of 50 were females. And 100 controls were also included on the basis of inclusion and exclusion criteria. Anthropometric data were measured following standard protocols. Biochemical investigations were done following proper method for each parameter. RESULTS AND OBSERVATION: 64% of subjects were between the age group of 40-60 and mean age was 55.34 ± 2.43years. 56% of the total subject has BMI more than 30.leptin levels were elevated in the cases group as compared to controls and the differences were statistically significant (p<0.0001). CONCLUSION: Present study concludes serum leptin level was significantly elevated in patients with diabetes when compared to non-diabetics healthy control group.
Cite this article:
Ranjit Ambad, Roshan Kumar Jha, Dhruba Hari Chandi, Saurabh Hadke. Association of Leptin in Diabetes Mellitus and Obesity. Research J. Pharm. and Tech. 2020; 13(12):6295-6299. doi: 10.5958/0974-360X.2020.01095.1
Cite(Electronic):
Ranjit Ambad, Roshan Kumar Jha, Dhruba Hari Chandi, Saurabh Hadke. Association of Leptin in Diabetes Mellitus and Obesity. Research J. Pharm. and Tech. 2020; 13(12):6295-6299. doi: 10.5958/0974-360X.2020.01095.1 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-12-110
REFERENCE:
1. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World journal of diabetes. 2015 Jun 25; 6(6):850.
2. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman medical journal. 2012 Jul; 27(4):269.
3. Ranjit Sidram Ambad, Gaikwad S B, Anshula G, Nandkishor Bankar. Polyherbal antidiabetic drug: An approach to cure diabetes. Int. J. Res. Pharm. Sci., 2020, 11(2), 2679-2683
4. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017 Jun 3;389(10085):2239-51.
5. Cladius, S., U. Jadhav, B. Ghewade, S. Ali, and T. Dhamgaye. “Study of Diabetes Mellitus in Association with Tuberculosis.” Journal of Datta Meghe Institute of Medical Sciences University 12, no. 2 (2017): 143–47.
6. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Annals of internal medicine. 2010 Jan 19;152(2):93-100.
7. Positional cloning of the mouse obese gene and its human homologue. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM Nature. 1994 Dec 1; 372(6505):425-32.
8. Licinio J, Mantzoros C, Negrão AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW Nat Med. 1997 May; 3(5):575-9.
9. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF J Clin Invest. 1996 Mar 1; 97(5):1344-7.
10. Mechanisms of leptin action and leptin resistance. Myers MG, Cowley MA, Münzberg H Annu Rev Physiol. 2008; 70():537-56.
11. Gawali R, Bahulikar A, Phalgune Ds, Tambolkar A. Association between Serum Leptin Levels in Obesity and Type 2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2019 Oct 1;13(10).
12. Ajonish Kamble, Ranjit S. Ambad, Mangesh Padamwar, Anupam Kakade, Meenakshi Yeola. To study the effect of oral vitamin D supplements on wound healing in patient with diabetic foot ulcer and its effect on lipid metabolism. Int. J. Res. Pharm. Sci., 2020, 11(2), 2701-2706.
13. Phadnis, P., M.A. Kamble, S. Daigavane, P. Tidke, and S. Gautam. “Prevalence and Risk Factors-Hemoglobin A1c, Serum Magnesium, Lipids, and Microalbuminuria for Diabetic Retinopathy: A Rural Hospital-Based Study.” Journal of Datta Meghe Institute of Medical Sciences University 12, no. 2 (2017): 121–32.
14. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. The journal of clinical endocrinology and metabolism. 1999 Jan 1;84(1):137-44.
15. Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A. Association between serum leptin concentrations and insulin resistance: a population-based study from China. PloS one. 2013 Jan 22;8(1):e54615.
16. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 1996;45(6):822-24.
17. Aziz N, Kallur SD, Nirmalan PK. Implications of the revised consensus body mass indices for Asian Indians on clinical obstetric practice. Journal of clinical and diagnostic research: JCDR. 2014 May;8(5):OC01.
18. Alberti KGMM, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. The Lancet 366: 1059–1062.
19. Roeschlau P, Brent E, Gruber W. Enzymatic determination of total cholesterol in serum. Clin Chem Clin Biochem. 1974;12(5):226-8.
20. Product data sheet, Triglyceride-G Code No 997-69801, Wako pure Chemical Industries Ltd. Dallas TX.
21. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A Peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983;29(3):538-42.
22. Fossati P, Principle L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077-80.
23. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11(6):583-95.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low- density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-04.
25. Mahajan S, Ambad RS, Jha RK, Mehta D, Koundal P. To Estimate Lipid Profile In Patients With Copd. International Journal of Medical and Biomedical Studies. 2020 Jan 17;4(1).
26. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942–6.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010 Jan 1;33(Supplement 1):S62-9.
28. Diwan AG, Kuvalekar AA, Dharamsi S, Vora AM, Nikam VA, Ghadge AA. Correlation of serum adiponectin and leptin levels in obesity and Type 2 diabetes mellitus. Indian Journal of Endocrinology and Metabolism. 2018;22(1):93.
29. Tatti P, Masselli L, Buonanno A, Di Mauro P, Strollo F. Leptin levels in diabetic and nondiabetic subjects. Endocrine. 2001;15(3):305-08.
30. McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, Leonnetti DL, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care. 1999;22(1):65-70.
31. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155-61.
32. Lele RD, Joshi SR, Gupte A. Association of adipocytokines (leptin, adiponectin TNF-alpha), insulin and proinsulin with diabetes- The Mumbai obesity project [MOP]. J Assoc Physicians India. 2006;54:689-96
33. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis. 1997;132(2):237-43.
34. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol. 1998; 18(6): 928-33.
35. Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: A prospective cohort study. Diabetologia. 2007;50(6):1178-85.